What additional laboratory tests are recommended for a patient with psoriasis and lumbar pain, beyond Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Psoriasis Patients with Lumbar Pain

For a patient with psoriasis presenting with lumbar pain, HLA-B27 testing and radiographic imaging of the sacroiliac joints and spine should be performed in addition to ESR and CRP to evaluate for psoriatic arthritis with axial involvement. 1

Core Laboratory Evaluation

When evaluating a patient with psoriasis who presents with lumbar pain, the following laboratory tests should be ordered:

  1. Inflammatory markers (already mentioned in question)

    • ESR (Erythrocyte Sedimentation Rate)
    • CRP (C-Reactive Protein)
  2. Essential additional tests

    • HLA-B27 - Critical for assessing risk of axial involvement 1
    • Complete blood count (CBC) - To evaluate for anemia, leukocytosis, and thrombocytosis 1, 2
    • Comprehensive metabolic panel - Including:
      • Liver enzymes (ALT, AST, ALP)
      • Renal function (BUN, creatinine)
      • Serum albumin (marker of inflammation and nutritional status) 1
  3. Immunological tests

    • Rheumatoid factor (RF) - To help differentiate from rheumatoid arthritis (typically negative in PsA) 1, 3
    • Anti-CCP antibodies - More specific for rheumatoid arthritis (typically negative in PsA) 3

Imaging Studies

Imaging is crucial for patients with psoriasis and lumbar pain:

  • Plain radiographs of the sacroiliac joints and lumbar spine - To detect structural changes 1
  • MRI of the sacroiliac joints and/or spine - To detect early inflammatory changes and monitor disease activity 1
    • STIR sequences are sufficient to detect inflammation without contrast medium 1

Additional Considerations

  • Fecal calprotectin - Consider if there are gastrointestinal symptoms to rule out inflammatory bowel disease, which can be associated with psoriatic arthritis 1
  • Infectious disease screening - Rule out infectious causes if acute flare is suspected:
    • Stool cultures
    • C. difficile toxin test 1
  • YKL-40 (Chitinase-3-like protein 1) - A newer inflammatory biomarker that may be more sensitive than CRP in detecting systemic inflammation in psoriasis 4

Interpretation of Results

  • Elevated inflammatory markers (ESR, CRP) attributable to psoriatic arthritis are considered indicators of severe disease and poor prognosis 1
  • However, it's important to note that ESR and CRP are elevated in only about 50% of patients with psoriatic arthritis 3, 5
  • Elevated inflammatory markers in obese patients may reflect adiposity-related inflammation rather than disease activity 6

Clinical Pearls and Pitfalls

  • Pearl: HLA-B27 positivity is associated with axial involvement in psoriatic arthritis and should guide treatment decisions
  • Pitfall: Normal ESR and CRP do not exclude active psoriatic arthritis with axial involvement
  • Pearl: TNF-α inhibitors appear more effective than IL-12/23 inhibitors in normalizing CRP levels 5
  • Pitfall: Obesity can elevate inflammatory markers independently of disease activity, potentially confounding interpretation 6

Remember that the diagnosis of psoriatic arthritis with axial involvement is based on a combination of clinical, laboratory, and imaging findings rather than any single test.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.